Top compounds associated with response to OR6C65


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib GDSC1000 pan-cancer AAC 0.063 0.07
mRNA Epothilone B GDSC1000 pan-cancer AAC -0.065 0.07
mRNA MPS-1-IN-1 GDSC1000 pan-cancer AAC 0.058 0.07
mRNA FK866 CTRPv2 pan-cancer AAC 0.066 0.07
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.07
mRNA AG-014699 GDSC1000 pan-cancer AAC -0.062 0.07
mRNA ruxolitinib GDSC1000 pan-cancer AAC -0.061 0.07
mRNA FH535 GDSC1000 pan-cancer AAC -0.063 0.07
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC -0.062 0.07
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.064 0.07
Download CSV